AMB-CHMINACA

AMB-CHMINACA
Legal status
Legal status	CA: Schedule II; DE: NpSG (Industrial and scientific use only); UK: Class B;
Identifiers
	IUPAC name methyl (2S)-2-{[1-(cyclohexylmethyl)indazole-3-carbonyl]amino}-3-methylbutanoate;
CAS Number	1863066-03-8(racemate);
PubChem CID	119026010;
ChemSpider	32055578;
UNII	OU56JJP891; Y21A13WADY(racemate);
CompTox Dashboard (EPA)	DTXSID601344891 ;
Chemical and physical data
Formula	C21H29N3O3
Molar mass	371.481 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC([C@H](C(C)C)NC(C1=NN(C2=C1C=CC=C2)CC3CCCCC3)=O)=O;
	InChI InChI=1S/C21H29N3O3/c1-14(2)18(21(26)27-3)22-20(25)19-16-11-7-8-12-17(16)24(23-19)13-15-9-5-4-6-10-15/h7-8,11-12,14-15,18H,4-6,9-10,13H2,1-3H3,(H,22,25)/t18-/m0/s1; Key:CRGGXDSTBHQLKJ-SFHVURJKSA-N;

AMB-CHMINACA or MMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid^[1] that is a potent agonist of the CB₁ receptor and has been sold online as a designer drug.^[2]^[3]^[4]

Quick Facts Legal status, Identifiers ...

Legal status